{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T05:48:36Z","timestamp":1677131316821},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,12,19]],"date-time":"2008-12-19T00:00:00Z","timestamp":1229644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00393-008-0415-1","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T11:49:46Z","timestamp":1229514586000},"page":"345-348","source":"Crossref","is-referenced-by-count":2,"title":["Cyclophosphamid oral vs. Bolus bei Wegener-Granulomatose und anderen ANCA-assoziierten Vaskulitiden"],"prefix":"10.1007","volume":"68","author":[{"given":"E.","family":"Reinhold-Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,19]]},"reference":[{"key":"415_CR1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY et al (1992) Wegener\u2019s granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488\u2013498","journal-title":"Ann Intern Med"},{"key":"415_CR2","first-page":"100","volume":"35","author":"Faurschou","year":"2008","unstructured":"Faurschou M, Sorensen IJ, Mellemkjaer L et al. (2008) Malignancies in Wegeners granulomatosis: Incidence and relation to cylophosphamide therapy in a cohort of 293 patients. J Rheumatol 35:100\u2013105","journal-title":"J Rheumatol"},{"key":"415_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.qjmed.a030133","volume":"89","author":"Reinhold-Keller","year":"1996","unstructured":"Reinhold-Keller E, Groot K de, Rudert H et al (1996) Response to trimethoprim\/sulfamethoxazole in Wegeners granulomatosis depends on the phase of disease. QJM 89:15\u201323","journal-title":"QJM"},{"key":"415_CR4","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"De","year":"2005","unstructured":"De Groot K, Rasmussen N, Bacon PA et al (2005) Randomized trial of cyclophosphamide vs. methotrexate for induction of remission in early systemic ANCA-associated vasculitis. Arthritis Rheum 52:2461\u20132469","journal-title":"Arthritis Rheum"},{"key":"415_CR5","unstructured":"Reinhold-Keller E, Aries P, Moosig F et al (2008) Verbessertes Langzeit-Outcome von 445 monozentrischen Patienten mit Wegenerscher Granulomatose \u00fcber vier Jahrzehnte. Med Klin 103 (Suppl 54)"},{"key":"415_CR6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2006.060301","volume":"66","author":"Stassen","year":"2007","unstructured":"Stassen PM, Cohen Tervaert JW, Stegeman CA (2007) Induction of remission in active ANCA-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis 66:798\u2013802","journal-title":"Ann Rheum Dis"},{"key":"415_CR7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","volume":"314","author":"Austin","year":"1986","unstructured":"Austin HA III, Klippel JH, le Riche NG et al (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614\u2013619","journal-title":"N Engl J Med"},{"key":"415_CR8","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","volume":"16","author":"Groot","year":"2001","unstructured":"Groot K de, Adu D, Savage COS (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16:2018\u20132027","journal-title":"Nephrol Dial Transplant"},{"key":"415_CR9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9343(90)90367-M","volume":"89","author":"Hoffman","year":"1990","unstructured":"Hoffman GS, Leavitt RY, Fleisher TA et al (1990) Treatment of Wegeners granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 89:403\u2013410","journal-title":"Am J Med"},{"key":"415_CR10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","volume":"43","author":"Reinhold-Keller","year":"2000","unstructured":"Reinhold-Keller E, Beuge N, Latza U et al (2000) An interdiciplinary approach to the care of patients with Wegener\u2019s granulomatosis. Arthritis Rheum 43:1021\u20131032","journal-title":"Arthritis Rheum"},{"key":"415_CR11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/ard.2003.019125","volume":"63","author":"Knight","year":"2004","unstructured":"Knight A, Askling J, Granath F et al (2004) Urinary bladder cancer in Wegener\u2019s granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis 63:1183\u20131185","journal-title":"Ann Rheum Dis"},{"key":"415_CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculits associated with antineutrophil cytoplasmic antiboides. N Engl J Med 349:36\u201344","journal-title":"N Engl J Med"},{"key":"415_CR13","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/1529-0131(200012)43:12<2854::AID-ANR31>3.0.CO;2-C","volume":"43","author":"Reinhold-Keller","year":"2000","unstructured":"Reinhold-Keller E, Groot K de, Gross WL (2000) Cystitis, bladder cancer and myelodysplasia in patients with Wegener\u2019s granulomatosis, letter to the editor. Arthritis Rheum 43:2854\u20132855","journal-title":"Arthritis Rheum"},{"key":"415_CR14","doi-asserted-by":"crossref","unstructured":"Villa-Forte A, Clark TM, Gomes M et al (2007) Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis. Medicine (Baltimore) 86:269\u2013277","DOI":"10.1097\/MD.0b013e3181568ec0"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0415-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0415-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0415-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:35:58Z","timestamp":1559061358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0415-1"}},"subtitle":["Pro und Contra"],"short-title":[],"issued":{"date-parts":[[2008,12,19]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0415-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,19]]}}}